Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.
ļ»æ

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(14)
•••
Post by jopatcloon Nov 09, 2024 1:27pm
95 Views
Post# 36304734

Happening now at #MedTechMalta2024! Benjamin Joas RieckšŸŽ¤

Happening now at #MedTechMalta2024! Benjamin Joas RieckšŸŽ¤Interesting on Linkedin comment  Bart Hendriks ( Likely the audience much appreciated sharing time with you. Free valuable inside knowledge from a seasons veteran. Good job Benjamin Joas Rieck! ) on post  MedTech Word .
Happening now at MedTechMalta2024! Benjamin Joas Rieck, CEO and General Manager, Angio Consult GmbH, is sharing invaluable insights on ‘From Concept to Care: Navigating the Journey of Cardiovascular Medical Devices from Design to Patient.’ His expertise is bringing each stage to life, from innovative design to patient impact. A powerful session for those dedicated to advancing cardiovascular care! 

Powered by: Angio Consult GmbH

See the event in photos with our LIVE coverage here: https://lnkd.in/dRpMH8tm

Supported by: Lifeblood, Malta Enterprise, VisitMalta Incentives & Meetings, Malta Digital Innovation Authority, Ministry for Health and Active Ageing, Government of Malta
 
 
 
 

 

 
Add a comment…
 
 
View Angio Consult GmbHs profile

Angio Consult GmbH

 
 
Thank you for spotlighting this great session and for having us in Malta!  We were thrilled to share how Angio Consult GmbH supports the journey from concept to patient impact in cardiovascular care. Huge thanks to MedTech World and all partners for making this possible!
 
 
 
 
 

Bart Hendriks • 3rd+

 
 
Likely the audience much appreciated sharing time with you. Free valuable inside knowledge from a seasons veteran. Good job Benjamin Joas Rieck!
 
 
 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities